About Option Care Health, Inc. - Common Stock (OPCH)
Option Care Health Inc is a leading provider of home and alternate site infusion services in the United States. The company specializes in delivering personalized intravenous (IV) medication therapies to patients in the comfort of their homes or in outpatient settings, focusing on critical care, oncology, and infectious diseases. Through a network of experienced healthcare professionals, Option Care Health ensures high-quality patient care and treatment, while also emphasizing collaboration with healthcare providers to improve health outcomes and enhance the overall patient experience. The company aims to be a trusted partner in the healthcare continuum, offering innovative solutions tailored to individual patient needs. Read More
Discover OPTION CARE HEALTH (OPCH), an affordable growth stock with strong earnings, solid profitability, and a reasonable valuation for sustainable expansion.
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%.
But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
OPCH stock shows strong fundamentals with accelerating EPS growth and a promising technical breakout pattern, positioning it for potential upward momentum.
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns.
Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
BANNOCKBURN, Ill., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, will participate in the following upcoming investor conferences:
A number of stocks fell in the afternoon session after the major indices continued to pull back, with technology stocks accounting for most of the market's largest decliners. A key reason for this trend is that much of the recent market gains were concentrated in the "AI trade," which includes these large technology and semiconductor companies. So this could also mean that some investors are locking in some gains ahead of more definitive feedback from the Fed.
Looking back on senior health, home health & hospice stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Option Care Health (NASDAQ:OPCH) and its peers.
Alternate site health provider Option Care Health (NASDAQ:OPCH) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 15.4% year on year to $1.42 billion. The company expects the full year’s revenue to be around $5.58 billion, close to analysts’ estimates. Its non-GAAP profit of $0.41 per share was 3.6% above analysts’ consensus estimates.
Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today announced that it has formed a strategic relationship with Option Care Health, Inc. (Nasdaq: OPCH), the nation’s largest independent provider of home and ambulatory infusion services, to support the commercial development and efficient launch of Quince’s lead asset, encapsulated dexamethasone sodium phosphate (eDSP) in the U.S., assuming positive study results and subsequent regulatory approval.
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on.
However, these companies often come with higher volatility and risk, as their smaller size makes them more vulnerable to economic downturns.
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold.
Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s punishment can be swift and severe when trajectories fall.
Alternate site health provider Option Care Health (NASDAQ:OPCH) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 15.4% year on year to $1.42 billion. The company expects the full year’s revenue to be around $5.58 billion, close to analysts’ estimates. Its non-GAAP profit of $0.41 per share was 3.3% above analysts’ consensus estimates.
Option Care Health (OPCH) reports strong Q2 2025 earnings, beating revenue and EPS estimates. Revenue hit $1.42B, up 15.4% YoY, with EPS at $0.41. Shares remain steady despite the positive results.
BANNOCKBURN, Ill., July 30, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the second quarter ended June 30, 2025.
Alternate site health provider Option Care Health (NASDAQ:OPCH)
will be announcing earnings results this Wednesday before the bell. Here’s what to look for.
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,
and over the past six months, the industry has pulled back by 6%. This drop is a stark contrast from the S&P 500’s 7.5% gain.
BANNOCKBURN, Ill., June 25, 2025 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced that the company will release results for its second quarter ended June 30, 2025 on Wednesday, July 30, 2025 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day.
